OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic in vivo delivery of gene editing agents
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 294

Showing 1-25 of 294 citing articles:

Advances in CRISPR therapeutics
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 114

Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice
Daniel Reichart, Gregory A. Newby, Hiroko Wakimoto, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 412-421
Open Access | Times Cited: 107

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing
Jianli Tao, Daniel E. Bauer, Roberto Chiarle
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 104

Prime editing: advances and therapeutic applications
Zhihan Zhao, Peng Shang, Prarthana Mohanraju, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 8, pp. 1000-1012
Open Access | Times Cited: 90

Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo
Meirui An, Aditya Raguram, Samuel W. Du, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 10, pp. 1526-1537
Open Access | Times Cited: 89

In vivo human T cell engineering with enveloped delivery vehicles
Jennifer Hamilton, Evelyn Chen, Barbara S. Perez, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 11, pp. 1684-1692
Open Access | Times Cited: 84

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 74

CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 73

GalNAc-Lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy
Lisa N. Kasiewicz, Souvik Biswas, Aaron Beach, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 62

RNA‐based medicine: from molecular mechanisms to therapy
Anke Sparmann, Jörg Vogel
The EMBO Journal (2023) Vol. 42, Iss. 21
Open Access | Times Cited: 55

Engineering RNA export for measurement and manipulation of living cells
Felix Horns, Joe A. Martinez, Chengcheng Fan, et al.
Cell (2023) Vol. 186, Iss. 17, pp. 3642-3658.e32
Open Access | Times Cited: 48

Vision rescue via unconstrained in vivo prime editing in degenerating neural retinas
Huan Qin, Wenliang Zhang, Shiyao Zhang, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 47

In vivo editing of lung stem cells for durable gene correction in mice
Yehui Sun, Sumanta Chatterjee, Xizhen Lian, et al.
Science (2024) Vol. 384, Iss. 6701, pp. 1196-1202
Closed Access | Times Cited: 43

Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing
Emily L. Han, Marshall S. Padilla, Rohan Palanki, et al.
Nano Letters (2024) Vol. 24, Iss. 5, pp. 1477-1486
Closed Access | Times Cited: 28

Designing nanotheranostics with machine learning
Lang Rao, Yuan Yuan, Xi Shen, et al.
Nature Nanotechnology (2024)
Closed Access | Times Cited: 22

A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20

Precise genome-editing in human diseases: mechanisms, strategies and applications
Yanjiang Zheng, Yifei Li, Kaiyu Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 18

Targeted nonviral delivery of genome editors in vivo
Connor A. Tsuchida, Kevin Wasko, Jennifer Hamilton, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 18

High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing
Nathan H. Lazar, Safiye Çelik, Lu Chen, et al.
Nature Genetics (2024) Vol. 56, Iss. 7, pp. 1482-1493
Open Access | Times Cited: 18

Tracking-seq reveals the heterogeneity of off-target effects in CRISPR–Cas9-mediated genome editing
Ming Zhu, Runda Xu, Junsong Yuan, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 18

Brain-Targeting Drug Delivery Systems: The State Of The Art In Treatment Of Glioblastoma
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 3

Delivering living medicines with biomaterials
Tetsuhiro Harimoto, Wei‐Hung Jung, David Mooney
Nature Reviews Materials (2025)
Closed Access | Times Cited: 3

Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells
Martin Panigaj, Tanaya Basu Roy, Elizabeth Skelly, et al.
ACS Nano (2025)
Open Access | Times Cited: 2

Advanced Delivery Systems for Gene Editing: A Comprehensive Review from the GenE-HumDi COST Action Working group
Alessia Cavazza, Francisco J Molina-Estévez, Álvaro Plaza Reyes, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102457-102457
Open Access | Times Cited: 2

Targeted Delivery of mRNA with Polymer–Lipid Nanoparticles for In Vivo Base Editing
Qimingxing Chen, Yan Chang, Xiaoyan He, et al.
ACS Nano (2025)
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top